Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD68/SR-D1 Antibody (FA-11) - BSA Free, Novus Biologicals™

Rat Monoclonal Antibody has been used in 29 publications
Supplier: Novus Biologicals NBP233337SS
Description
CD68/SR-D1 Monoclonal specifically detects CD68/SR-D1 in Mouse samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Functional, Flow (Intracellular), Single Cell Western.Specifications
CD68/SR-D1 | |
Monoclonal | |
1.0 mg/mL | |
Western Blot 1:100-1:2000, Flow Cytometry 1:50-1:100, Immunohistochemistry 1:10-1:500. Use reported in scientific literature (PMID 34478932), Immunocytochemistry/Immunofluorescence 1:10-1:500. Use reported in scientific literature (PMID 34478932), Immunoprecipitation 1:10-1:500, Immunohistochemistry-Paraffin 1:10-1:500, Immunohistochemistry-Frozen 1:10-1:500, Functional reported in scientific literature (PMID 11085350), Flow (Intracellular), Single Cell Western | |
P31996 | |
CD68 | |
This CD68/SR-D1 Antibody (FA-11) was developed against purified ConA acceptor glycoproteins from the P815 cell line. | |
0.025 mg | |
Cell Biology, Cytokine Research, Immunology, Microglia Markers | |
968 | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG2a |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation | |
FA-11 | |
Unconjugated | |
PBS with 0.02% Sodium Azide | |
CD68 antigenmacrophage antigen CD68, CD68 molecule, DKFZp686M18236, GP110, macrosialin, SCARD1, scavenger receptor class D, member 1 | |
Rat | |
Protein G purified | |
RUO | |
Primary | |
Mouse | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction